Industries — page 18
Take-Two Bookings Slip as Mobile Revenue Retreats
The videogame publisher recorded a $43.4 million impairment charge after halting an unannounced title.
Treace Lifts 2026 Sales Floor After Narrower Revenue Drop
Second-quarter sales were $45.4 million, a 4% year-over-year decline that improved from the first quarter’s 10% drop.
Interface Lifts Outlook as Margins Widen
Second-quarter net sales rose 5.4% to $395.7 million.
Tredegar Extrusions Profit Recovers After a First-Quarter Dip
Aluminum Extrusions EBITDA from ongoing operations reached $14.5 million in the second quarter, and the company said a $4.9 million FIFO aluminum benefit that lifted the year-over-year comparison is expected to be substantially neutralized in the third quarter.
Spectrum Brands Swings to Loss on HPC Impairment Despite Sales Surge
Spectrum Brands Holdings posted a $20.3 million net loss in its fiscal third quarter even as net sales rose 7.7% and adjusted EBITDA more than doubled.
Fluor Awards Jump as Revenue Returns to Growth
Adjusted EBITDA rose to $149 million, more than doubling from the first quarter.
Embecta Raises Profit Outlook After Rebound From March Slump
Embecta raised its adjusted earnings forecast to $1.80 to $1.90 a share for fiscal 2026 while holding its reported revenue guidance steady.
Ellington Financial's Profit Slides as Litigation Gain Fades
Ellington Financial reported net income of $54.4 million, or $0.43 a share, for the second quarter of 2026, down from $95.5 million a year earlier as one-time gains rolled off.
Artesian's Wastewater Mix Widens as Water Growth Cools
Second-quarter revenue reached $30.7 million as other utility operating revenue rose 16.0% and water sales rose 5.8%.
Yum China to Buy Pizza Hut Mainland China Brand for $1.2 Billion
Owning the Pizza Hut brand outright in China frees Yum China from license fees to Yum! Brands, a step the company says will push Pizza Hut's margins toward KFC's and speed up store openings.
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals to Expand Retina Pipeline
The acquisition adds a Phase 3 clinical program for Stargardt disease as Tarsus seeks to increase its presence in the high-growth retina specialty.
Nuvei to Acquire Payoneer in $2.75 Billion Cash Deal
The acquisition combines Nuvei's payment acceptance with Payoneer's cross-border payouts to create a global financial infrastructure leader.
Stratasys to Buy MarkForged in $42.5 Million Cash Deal
The acquisition is intended to reduce annualized cash burn by approximately $15 million and enhance financial flexibility.
Karman Holdings to Buy Walker Precision Engineering in $94 Million Deal
The acquisition is intended to expand Karman's footprint within the European defense market.
iRhythm to Buy Vital Connect in $287.5 Million Cardiac-Monitoring Deal
iRhythm said the acquisition would immediately widen its addressable market and push the company beyond ambulatory cardiac monitoring into a broader cardiac monitoring and intelligence platform.
Harrow to Buy TYRVAYA Assets in Deal Worth Up to $100 Million
The asset purchase would add a second mechanism of action to Harrow’s dry-eye portfolio alongside VEVYE.
Guardian Pharmacy Services to Acquire Wellness Concepts
The acquisition expands Guardian's geographic footprint in the Shenandoah Valley through the addition of a Virginia-based long-term care pharmacy.
Nielsen to Buy DoubleVerify in Merger Deal
DoubleVerify withdrew its outlook and suspended investor calls while the Nielsen transaction remained pending.
Dream Finders to Buy Beazer Homes in $2.2 Billion All-Cash Deal
The agreement caps a three-month public campaign by Dream Finders and creates the nation's sixth-largest homebuilder with more than $100 million in expected annual cost synergies.
Dream Finders Homes to Buy Beazer Homes in $2.2 Billion Cash Deal
The acquisition will create the sixth-largest U.S. homebuilder by revenue, with Dream Finders targeting double-digit EPS accretion in the first full year.
Brady Completes $1.4 Billion Cash Purchase of Honeywell's PSS Unit
The deal folds Honeywell's mobile-computing and scanning business into Brady's identification and safety portfolio, pushing the combined company into a $9 billion productivity-solutions market.
ARKO to Buy U.S. Petroleum Partners Business for $205 Million
The transaction would broaden ARKO Petroleum’s platform and accelerate the growth strategy set at its initial public offering.
Loan Stress Moves Into Foreclosures
Credit stress intensified across four US lenders and finance companies as higher rates pushed concentrated loan problems from modification into foreclosure and charge-off activity.
Zoetis Cuts Outlook as U.S. Pet-Drug Weakness Persists
The animal-health company lowered its full-year adjusted earnings forecast to $6.15 to $6.25 a share.
Zentalis Completes DENALI Enrollment, Pushes Readout to 2027
Cash, cash equivalents and marketable securities stood at $174.6 million as of June 30, 2026, which the company said funds operations into late 2027.
Whitehawk Extends Cash Runway Into Second Half of 2028
Cash, cash equivalents and short-term investments reached $190.0 million after an $87.5 million May private placement, and the company said that balance is anticipated to fund operations into 2H 2028.
Warner Bros. Discovery Profit Craters Ahead of Paramount Deal
Warner Bros. Discovery (WBD) reported net income tumbled 91% to $149 million as Studios weakness deepened even while streaming carried the quarter.
Voyager’s Alzheimer’s Gene Therapy Cleared For Human Testing
Voyager ended June with $148.8 million in liquid resources and said it expects two Alzheimer’s development milestones in the fourth quarter.
TechTarget Reverses First-Quarter Growth and Restates 2026 Targets
Second-quarter revenue was $116.1 million, down 3.2% from a year earlier, after a 2.1% year-over-year increase in the first quarter.
Targa Posts Record EBITDA as Fee-Based Growth Accelerates
Second-quarter adjusted EBITDA reached $1.603 billion, up 14% sequentially.
TriSalus Restores Sequential Revenue After Expansion Dip
TriNav sales reached $11.4 million in the second quarter as the company kept 2026 guidance at $54 million to $57 million.
BlackRock TCP Capital Sells $523 Million Portfolio Stake
The sale is expected to cut net leverage to about 0.4x and trim NAV by $0.68 a share.
Molson Coors Volume Slide Deepens as Costs Escalate
Molson Coors Beverage (TAP-A) reported second-quarter net sales fell 3.3% to $3.10 billion as volume declined 5.4% and mark-to-market commodity losses cut into profit.
Silvaco Posts First Non-GAAP Operating Profit in Two Years
Second-quarter revenue of $17.8 million rose 48% after 26% growth in the first quarter, and non-GAAP operating income reached $0.6 million.
SIGA Completes 19C Stockpile Deliveries After Quiet Quarters
The smallpox-drug maker booked $41.0 million of revenue and $12.5 million of net income in the three months ended June 30, 2026, after two consecutive quarters of losses.
Runway Growth Restores Net Investment Income After SWK Close
Net investment income was $18.2 million, or $0.43 a share, as the specialty finance company closed the SWK Holdings deal and lifted the portfolio to $1.2 billion.
Cartesian Extends Cash Runway Into 2028 After K2HV Loan
Cash, cash equivalents and restricted cash stood at $149.3 million after a $50 million K2 HealthVentures term loan and $19.3 million of year-to-date ATM proceeds.
BRC Group's Core Operating Profit Reaches Highest Since Late 2023
Operating Adjusted EBITDA was $66.0 million in the second quarter as net income available to common shareholders was $18.5 million.
AVITA Medical Raises 2026 Guidance After Record Quarter
Second-quarter revenue hit a record $21.7 million, up 18% from a year earlier, and the company lifted its full-year range to $86 million to $89 million.
Ready Capital’s Distributable Loss Narrowed After First-Quarter Widening
Ready Capital reported a distributable loss of $0.47 a share for the June quarter while keeping its focus on fourth-quarter debt maturities.
CPI Card Group Lifts 2026 Revenue and Cash-Flow Outlook
Second-quarter revenue rose 15% to $149.2 million as the company raised 2026 free-cash-flow guidance to $45 million–$50 million.
Palladyne AI Reiterates 2026 Guidance After Record Quarter
Second-quarter revenue reached $5.8 million, and the company kept its $24 million to $27 million full-year outlook intact.
Montauk's Second-Quarter Revenue Growth Accelerates
Revenue reached $54.0 million, up 19.7% from a year earlier, as Adjusted EBITDA rose 144.5% to $12.3 million.
Lee Raises Fiscal 2026 Ebitda Outlook After Profit Return
The company now expects 22% to 28% year-over-year Adjusted EBITDA growth, after a $5 million net income in the quarter ended June 28, 2026.
Lifetime Brands Raises 2026 Earnings Outlook After Tariff Refunds
The home-products marketer booked a $40.1 million tariff refund, swung to $19.6 million of net income, or $0.87 a share, and lifted full-year profit guidance.
Lineage Chose Animal Testing for New Corneal Cell Therapy
The biotechnology developer reported $4.8 million in quarterly research spending as its new COR1 eye-disease program cleared internal criteria for further preclinical work.
Kenvue Sales Rise as Volume Growth Returns
Adjusted earnings rose 7% to $0.31 a share despite pressure from tariffs and inflation.
Korro Bio Adds Drug Candidate for Genetic Liver and Lung Disease
The RNA-editing drug developer ended June with $137.9 million in cash and securities, which it expects to fund operations into the second half of 2028.
Keurig Dr Pepper Profit Rebounded After JDE Peet’s Acquisition
Net sales reached $7.31 billion after the April acquisition transformed the beverage maker’s business.
Howmet Raises Outlook as Aerospace Demand Accelerates
Second-quarter revenue reached $2.547 billion, topping the high end of Howmet’s prior guidance by $137 million.